Arkolith/Insider Trading/CKPT/Form 4

Fortress Biotech, Inc.

10% OwnerCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Jun 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$129K
Net Open-Market Flow
-$129K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2025Disposed to issuer(D)6.1M$4.10$25.1M0
May 29, 2025Sell(S)100K$1.29$129K6.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 30, 2025Disposed to issuer(D)700K—$00

Transaction Codes

D
Disposition to the issuer
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-015470) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML